CDK2 and gastric cancer: Considering the impact of LETM2 on cell cycle progression in gastric cancer, we conducted Western Blot experiments to evaluate the expression of G0/G1 phase-associated cyclins, CDK2, CDK4, CDK6, CyclinB1, and CyclinE2.